TScan Therapeutics - 53 Year Dividend History | TCRX
Historical dividend payout and yield for TScan Therapeutics (TCRX) since 1971. The current TTM dividend payout for TScan Therapeutics (TCRX) as of April 18, 2024 is $0.00. The current dividend yield for TScan Therapeutics as of April 18, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.323B |
$0.021B |
|
TScan Therapeutics Inc. is a biopharmaceutical company. It focused on the development of T-cell receptor engineered T cell therapies for the treatment of patients with cancer. The company's lead product pipeline consist TSC-100 and TSC-101. TScan Therapeutics Inc. is based in WALTHAM, Mass.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
